Analysis of drug utilization in Serbia during the years 1996 and 1997

Pharmacoepidemiology and Drug Safety

Volumn 9, Issue 1, 2000, Pages 59-64

  Milena, Miljković ^a,b   Ljiljana, Djukić ^a  

^a Institute of Pharmacy of Serbia   (Yugoslavia)

^b Institute of Pharmacy of Serbia   (Yugoslavia)

Author keywords

Community pharmacies; Defined daily doses; Drug utilization; Prescribed medications; Rational pharmacotherapy

Indexed keywords

AMILORIDE; AMOXICILLIN; AMPICILLIN; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; ATENOLOL; CAPTOPRIL; CEFALEXIN; DIAZEPAM; DICLOFENAC; DIGOXIN; DIURETIC AGENT; FLURBIPROFEN; FUROSEMIDE; GLIBENCLAMIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; INDAPAMIDE; METHYCLOTHIAZIDE; NIFEDIPINE; PENICILLIN G; PENTOXIFYLLINE; PRAZEPAM; PYRIDOXINE; RANITIDINE; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNINDEXED DRUG;

ARTICLE; BUDGET; DATA ANALYSIS; DRUG UTILIZATION; HEALTH INSURANCE; HUMAN; PHARMACODYNAMICS; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; YUGOSLAVIA;

EID: 0034014840     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(200001/02)9:1<59::AID-PDS464>3.0.CO;2-E     Document Type: Article

References (13)

1. WHO Expert Committee. The Selection of Essential Drugs. Technical Report Series, No. 615. World Health Organization, Geneva, 1977.
2. Hogerzeil HV. Promoting rational prescribing: an international perspective. Br J Clin Pharmacol 1995; 36: 1-6.
3. Drug Utilization Database. (computer program) of the Institute of Pharmacy of Serbia, Belgrade (FRY). 1998.
4. Wessling A. Continuous recording of drug prescribing in Sweden 1974-1983. Methods and examples of utilization data. Eur J Clin Pharmacol 1987; 33: 7-13.
5. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs. World Health Organization: Oslo, 1998.
6. David L, Ulf B. Studies of drug utilization. Pharmacoepidemiology (2nd edn), Strom BL (ed.). John Wiley & Sons Ltd: Chichester, 1998; 379-394.
7. Stanulovic M, Milosev M, Jakovljevic V, Roncevic N. Epidemiological evaluation of anti-infective drug prescribing for children in outpatient practice. Dev Pharmacol Ther 1987; 10: 278-291.
8. Institute of Health Care of Serbia. Health State of Population in Serbia. The Institute of Health Care of Serbia: Belgrade, 1998.
9. Schaefler P, Vigne P, Frelin C, Lazdunski M. Identification and pharmacological properties of binding sites for the atypical thiazide diuretic, indapamide. Eur J Pharmacol 1990; 182(3): 503-508.
10. Reynolds JEF (Ed.). Antibacterial agents. Martindale - The Extra Pharmacopoeia (31st edn). The Royal Pharmaceutical Society: London, 1996; 129-299.
11. Mandell GL, Petri WA Jr. Antimicrobial agents: penicillins, cephalosporins, and other beta-lactam antibiotics. Goodman & Gilman's The Pharmacological Basis of Therapeutics (9th edn), Hardman JG, Limbrid LE, Molinoff PB, Ruddon RW, Goodman and Gilman A (eds). McGraw Hill Companies Inc: New York, 1996; 1073-1103.
12. Chambers HF, Sande MA. Antimicrobial agents: general considerations. Goodman & Gilman's The Pharmacological Basis of Therapeutics (9th edn), Hardman JG, Limbrid LE, Molinoff PB, Ruddon RW, Goodman and Gilman A (eds). McGraw Hill Companies Inc: New York, 1996; 1029-1057.
13. Spratt BG. Resistance to antibiotics mediated by target alterations. Science 1994; 264: 388-399.